Sep 30, 2026
Citi Downgrades Moderna (MRNA) Stock to Sell After 222% Rally
Citi downgrades Moderna (MRNA) to Sell with $80 target, citing valuation concerns after 222% rally. Stock falls 5.7% on bearish call from analyst.
The post Citi Downgrades Moderna (MRNA) Stock to Sell After 222% Rally appeared first on Blockonomi.
Source: Blockonomi →Related News
- 57 minutes ago
UNI Wallet Creation Reaches Highest Level Since November 2022
- 1 hour ago
Rocket Lab (RKLB) Stock: Surges as Electron Completes 98th Launch for HawkEye 36...
- 4 hours ago
Cosmos (ATOM) Price Prediction: Can ATOM Reach $15?
- 4 hours ago
XRP News: Why Korea’s KYC-Ready Traders Could Fast-Track XRP Tokenization
- 7 hours ago
Robinhood sees surge in bitcoin, gold prediction markets as traders move beyond...